Both in Pharmaceuticals
Moleculin Biotech vs Curanex Pharmaceuticals
Over the past year MBRX returned −96.8% and CURX returned −56.5%; their daily moves had a correlation of -0.00.
MBRX −96.8% CURX −56.5%Growth of $1, one year, split-adjusted
| Metric | MBRX | CURX |
|---|---|---|
| Price | $8.32 | $5.85 |
| Market cap | $8.5M | $9.2M |
| Today | +5.32% | +13.37% |
| 1 month | −14.5% | +23.9% |
| 6 months | −83.2% | −22.0% |
| Year to date | −87.4% | −11.5% |
| 1 year | −96.3% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $7.3M | $2.9M |
| Dividend yield | — | — |
| Volatility (60d) | 850.8% | 905.0% |
| Short % of float | 0.7% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).